These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 1786522)
1. Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin. Le Monnier de Gouville AC; Cavero I Br J Pharmacol; 1991 Sep; 104(1):77-84. PubMed ID: 1786522 [TBL] [Abstract][Full Text] [Related]
2. Differential pharmacological profile of endothelin-1 and its precursor, big endothelin. Le Monnier de Gouville AC; Cavero I J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S362-5. PubMed ID: 1725381 [TBL] [Abstract][Full Text] [Related]
3. The effects of phosphoramidon on the regional haemodynamic responses to human proendothelin [1-38] in conscious rats. Gardiner SM; Compton AM; Kemp PA; Bennett T Br J Pharmacol; 1991 Aug; 103(4):2009-15. PubMed ID: 1912989 [TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats. Le Monnier de Gouville AC; Mondot S; Lippton H; Hyman A; Cavero I J Pharmacol Exp Ther; 1990 Jan; 252(1):300-11. PubMed ID: 2405151 [TBL] [Abstract][Full Text] [Related]
5. Inhibition by phosphoramidon of the regional haemodynamic effects of proendothelin-2 and -3 in conscious rats. Gardiner SM; Kemp PA; Bennett T Br J Pharmacol; 1992 Oct; 107(2):584-90. PubMed ID: 1422599 [TBL] [Abstract][Full Text] [Related]
6. Effects of the neutral endopeptidase inhibitor, SQ 28,603, on regional haemodynamic responses to atrial natriuretic peptide or proendothelin-1 [1-38] in conscious rats. Gardiner SM; Kemp PA; Bennett T Br J Pharmacol; 1992 May; 106(1):180-6. PubMed ID: 1387023 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the cardiovascular and neural activity of endothelin-1, -2, -3 and respective proendothelins: effects of phosphoramidon and thiorphan. Mattera GG; Eglezos A; Renzetti AR; Mizrahi J Br J Pharmacol; 1993 Sep; 110(1):331-7. PubMed ID: 8106108 [TBL] [Abstract][Full Text] [Related]
8. Endothelium-dependent mesenteric vasorelaxant effects and systemic actions of endothelin (16-21) and other endothelin-related peptides in the rat. Douglas SA; Hiley CR Br J Pharmacol; 1991 Oct; 104(2):311-20. PubMed ID: 1797300 [TBL] [Abstract][Full Text] [Related]
9. Endothelium-dependent vascular activities of endothelin-like peptides in the isolated superior mesenteric arterial bed of the rat. Douglas SA; Hiley CR Br J Pharmacol; 1990 Sep; 101(1):81-8. PubMed ID: 2282471 [TBL] [Abstract][Full Text] [Related]
10. Coeliac haemodynamic effects of endothelin-1, endothelin-3, proendothelin-1 [1-38] and proendothelin-3 [1-41] in conscious rats. Gardiner SM; Kemp PA; Compton AM; Bennett T Br J Pharmacol; 1992 Jun; 106(2):483-8. PubMed ID: 1393273 [TBL] [Abstract][Full Text] [Related]
11. Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1. Matsumura Y; Hisaki K; Takaoka M; Morimoto S Eur J Pharmacol; 1990 Aug; 185(1):103-6. PubMed ID: 2226629 [TBL] [Abstract][Full Text] [Related]
13. Vasodilator activity of endothelin-1 and endothelin-3: rapid development of cross-tachyphylaxis and dependence on the rate of endothelin administration. Le Monnier de Gouville AC; Lippton H; Cohen G; Cavero I; Hyman A J Pharmacol Exp Ther; 1990 Sep; 254(3):1024-8. PubMed ID: 2118569 [TBL] [Abstract][Full Text] [Related]
14. Big endothelin-3-induced hypertension and its inhibition by phosphoramidon in anaesthetized rats. Matsumura Y; Fujita K; Takaoka M; Morimoto S Eur J Pharmacol; 1993 Jan; 230(1):89-93. PubMed ID: 8094056 [TBL] [Abstract][Full Text] [Related]
15. Phosphoramidon inhibits the conversion of big ET-1 into ET-1 in the pithed rat and in isolated perfused rat kidneys. Verbeuren TJ; Mennecier P; Merceron D; Simonet S; de Nanteuil G; Vincent M; Laubie M J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S81-4. PubMed ID: 7510006 [TBL] [Abstract][Full Text] [Related]
16. Effects of moderate hypoxia, hypercapnia and acidosis on haemodynamic changes induced by endothelin-1 in the pithed rat. MacLean MR; Randall MD; Hiley CR Br J Pharmacol; 1989 Nov; 98(3):1055-65. PubMed ID: 2511990 [TBL] [Abstract][Full Text] [Related]
17. Analysis of responses to big endothelin in the hindquarters vascular bed of the cat. Tamura DY; Minkes RK; Bellan JA; McMahon TJ; McNamara DB; Kadowitz PJ Can J Cardiol; 1992 Nov; 8(9):954-60. PubMed ID: 1486546 [TBL] [Abstract][Full Text] [Related]
18. Regional haemodynamic effects of endothelin-1 and endothelin-3 in conscious Long Evans and Brattleboro rats. Gardiner SM; Compton AM; Bennett T Br J Pharmacol; 1990 Jan; 99(1):107-12. PubMed ID: 2139584 [TBL] [Abstract][Full Text] [Related]
19. Why big endothelin-1 lacks a vasodilator response. Haleen SJ; Davis LS; LaDouceur DM; Keiser JA J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S271-3. PubMed ID: 7509963 [TBL] [Abstract][Full Text] [Related]
20. Role of endothelin-converting enzyme in the systemic hemodynamics and regional circulatory effects of proendothelin-1 (1-38) and diaspirin cross-linked hemoglobin in rats. Gulati A; Singh R; Chung SM; Sen AP J Lab Clin Med; 1995 Dec; 126(6):559-70. PubMed ID: 7490515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]